About FDA
Review Performance At-A-Glance for FY 2005 and FY 2006
The horizontal bar graph provides FDA actual and preliminary "on-time" performance on six actions related to original and resubmitted NDA and BLA applications. All on-time goals are at 90 percent of actions. Performance results for FY 2005 and preliminary performance results for FY 2006 show that, with one exception, FDA is meeting or exceeding the performance levels that were set for each of these goals. The one exception relates to an FDA on-time goal during FY 2005 to review and act on priority NDAs and BLAs where FDA performance was slightly below the 90 percent goal.
Original and Resubmitted Efficacy Supplements
The horizontal bar graph provides FDA actual and preliminary "on-time" performance on five actions related to original and resubmitted efficacy supplements to NDAs and BLAs. On-time goals range from 70 to 90 percent of actions. Performance results for FY 2005 and preliminary performance results for FY 2006 show that FDA is exceeding all five goals.
Manufacturing Supplements
The horizontal bar graph provides FDA actual and preliminary "on-time" performance on two actions related to manufacturing supplements to NDAs and BLAs. Both on-time goals are at 90 percent of actions. Performance results for FY 2005 and preliminary performance results for FY 2006 shows that FDA is exceeding both goals.
